Holen Sie sich die Stockscreener-App
241.12
1.11%
-2.71
Handel nachbörslich:
241.12
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
How sensitive is West Pharmaceutical Services Inc. to inflationGold Moves & Weekly Breakout Watchlists - mfd.ru
West Pharmaceutical Services (WST) is Returning to Sustainable Volume Growth - Insider Monkey
Vanguard Group Inc. Buys 388,144 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Sold by ICICI Prudential Asset Management Co Ltd - MarketBeat
Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock? - Yahoo Finance
Customer Concentration Risk: How Dependence on Key Accounts Threatens West Pharmaceutical’s Financial Stability - The Globe and Mail
Risk Recap: What’s the outlook for West Pharmaceutical Services Inc.’s sectorWeekly Trend Recap & AI Enhanced Market Trend Forecasts - mfd.ru
Pharmaceutical Packaging Market Trends and Growth - GlobeNewswire
Pharmaceutical Packaging Market Trends and Growth Projections to 2030 Featuring Profiles of AptarGroup, Amcor, SGD Pharma, West Pharmaceutical Services, SCHOTT Pharma and Other Key Players - Yahoo Finance
Exton-Based West Pharmaceutical Reports Higher Q4 Sales, Earnings - MyChesCo
5 Insightful Analyst Questions From West Pharmaceutical Services's Q4 Earnings Call - Finviz
5 Insightful Analyst Questions From West Pharmaceutical Services’s Q4 Earnings Call - TradingView
Assessing West Pharmaceutical Services (WST) Valuation After Earnings Beat Guidance And US$1b Buyback Announcement - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP), Galapagos (GLPG) and West Pharmaceutical Services (WST) - The Globe and Mail
West Pharmaceutical Services, Inc. (NYSE:WST) Declares $0.22 Quarterly Dividend - MarketBeat
Assetmark Inc. Sells 26,486 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Share Repurchase Plan Declared by West Pharmaceutical Services (NYSE:WST) Board of Directors - Defense World
West Pharmaceutical Services (NYSE:WST) to Buyback $1.00 billion in Outstanding Shares - MarketBeat
West Pharmaceutical announces up to $1B share repurchase program - MSN
West Pharmaceutical Services Maintains Quarterly Dividend, Authorizes $1 Billion Share Repurchase - marketscreener.com
West Pharmaceutical Services, Inc. Declares Regular Quarterly Dividend on Common Stock, Payable on May 6, 2026 - marketscreener.com
West Pharmaceutical Declares Quarterly Dividend and Share Repurchase Program - Intellectia AI
West Announces Quarterly Dividend and Share Repurchase Program - Nasdaq
Why West Pharmaceutical Services (WST) is a Top Growth Stock for the Long-Term - Yahoo Finance
How West Pharmaceutical Services Inc. (WST) Affects Rotational Strategy Timing - Stock Traders Daily
West Pharmaceutical Services launches Synchrony S1 prefillable syringe system - Traders Union
West Pharmaceutical Services (WST) Stock Analysis: A Look At Its 27% Potential Upside - DirectorsTalk Interviews
WST's Q4 earnings & sales beat, SmartDose sale by mid-2026, stock up - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) Sees Significant Increase in Short Interest - MarketBeat
What’s the outlook for West Pharmaceutical Services Inc.’s sectorPrice Action & Technical Confirmation Alerts - mfd.ru
Earnings Release: Here's Why Analysts Cut Their West Pharmaceutical Services, Inc. (NYSE:WST) Price Target To US$319 - 富途牛牛
Cibc World Market Inc. Has $4.88 Million Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Caprock Group LLC Purchases New Shares in West Pharmaceutical Services, Inc. $WST - MarketBeat
How Investors Are Reacting To West Pharmaceutical (WST) GLP-1 Momentum And Upbeat 2026 Sales Guidance - Sahm
West Pharmaceutical Services (WST): Barclays Lowers Price Target - GuruFocus
Stephens Cuts Price Target on West Pharmaceutical Services to $320 From $350, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2025 Earnings Call Transcript - Insider Monkey
West Pharmaceutical Services Q4 Earnings Call Highlights - MarketBeat
West Pharmaceutical targets 5%–7% organic revenue growth for 2026 as HVP demand accelerates - MSN
West Pharma forecasts 2026 profit above estimates on strong demand for drug components - 104.1 WIKY
West Pharmaceutical Services (WST) Is Up 5.2% After Strong 2025 Results And 2026 Organic Growth Outlook - Yahoo Finance
Earnings call transcript: West Pharmaceutical Services Q4 2025 earnings beat expectations - Investing.com Canada
West Pharmaceutical Q4 2025 slides: Revenue up 7.5%, EPS exceeds expectations - Investing.com Nigeria
West Pharmaceutical Services (NYSE:WST) Issues Quarterly Earnings Results, Beats Expectations By $0.21 EPS - MarketBeat
West Pharmaceutical Services Reports Strong Q4 2025 Earnings and Positive Outlook - Intellectia AI
West Pharmaceutical Services's (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars - Finviz
WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up - Finviz
Iron Mountain Projects Double-Digit Growth in 2026 - Investing.com
West Pharmaceutical Q4 2025 slides: Revenue up 7.5%, EPS exceeds expectations By Investing.com - Investing.com India
West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
West Pharmaceutical Services (NYSE:WST) Issues FY 2026 Earnings Guidance - MarketBeat
West Pharmaceutical Q4 EPS Beats Estimates; Guides 2026 Sales Growth of 5% to 7% - AlphaStreet News
West Pharmaceutical (WST) Exceeds Market Expectations with Stron - GuruFocus
West Pharmaceutical Services, Inc. $WST Shares Sold by ING Groep NV - MarketBeat
0.39%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):